Clinical Trials Browser

OTHER × Mifepristone × Genitourinary × Clear all

NCT02012296 2022-07-13

Enzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate Cancer

Phase 1/2 Completed

88 enrolled 14 charts

Prostatic Neoplasms

NCT00140478 2009-12-09

Mifepristone (RU-486) in Androgen Independent Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms